Correction to "N-(Pyrimidin-2-yl)-1,2,3,4-tetrahydroisoquinolin-6-amine Derivatives as Selective Janus Kinase 2 Inhibitors for the Treatment of Myeloproliferative Neoplasms".
Tao YangMengshi HuYong ChenMingli XiangMinghai TangWenyan QiMingsong ShiJun HeXue YuanChufeng ZhangKongjun LiuJiewen LiZhuang YangLi-Juan ChenPublished in: Journal of medicinal chemistry (2021)
Keyphrases